Prostate cancer now most commonly diagnosed cancer in the UK

An analysis by Prostate Cancer UK found 64,425 prostate cancer diagnoses in 2022, slightly more than 61,640 breast cancer cases; the charity highlighted regional differences in testing and in the stage at diagnosis.

Prostate Cancer UK analysed NHS data and reported that prostate cancer had more recorded diagnoses across the UK in 2022 than breast cancer. The charity cited 64,425 prostate cancer cases compared with 61,640 breast cancer cases. It also raised concerns about regional differences in testing and in how late the disease is diagnosed. Key facts: - Prostate Cancer UK reported 64,425 prostate cancer diagnoses in 2022 and 61,640 breast cancer diagnoses. - The analysis showed regional differences in stage at diagnosis, for example 31% of men in Scotland were reported as being diagnosed at stage 4 compared with 21% in England. - PSA testing rates varied by region, with the south-east of England reported as having the highest rates and the north-west the lowest. - The UK National Screening Committee recommended targeted screening for men with confirmed BRCA1 or BRCA2 gene variants rather than screening the majority of men. Summary: The analysis indicates prostate cancer has become the most commonly diagnosed cancer across the UK and highlights geographic and socioeconomic differences in testing and stage at diagnosis. Officials and bodies cited in the report point to targeted screening for people with specific genetic risk and to NHS actions such as expanded access to a treatment announced by the Department of Health and Social Care as part of ongoing measures; further policy decisions and wider screening plans are undetermined at this time.